Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients.
Hemodial Int. 2012 Jan;16(1):11-9. doi: 10.1111/j.1542-4758.2011.00608.x.
Hemodial Int. 2012.
PMID: 22098689
Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.
Heidenreich S, Leistikow F, Zinn S, Baumann J, Atzeni A, Bajeski V, Dietzmann J, Dragoun GP; SUPRA Study Group.
Heidenreich S, et al.
Clin Drug Investig. 2012 Feb 1;32(2):99-110. doi: 10.2165/11594040-000000000-00000.
Clin Drug Investig. 2012.
PMID: 22117178
Clinical Trial.
Item in Clipboard
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.
Carrera F, Lok CE, de Francisco A, Locatelli F, Mann JF, Canaud B, Kerr PG, Macdougall IC, Besarab A, Villa G, Kazes I, Van Vlem B, Jolly S, Beyer U, Dougherty FC; PATRONUS Investigators.
Carrera F, et al.
Nephrol Dial Transplant. 2010 Dec;25(12):4009-17. doi: 10.1093/ndt/gfq305. Epub 2010 Jun 3.
Nephrol Dial Transplant. 2010.
PMID: 20522670
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite